

Fundamental dimension Equity attribute | AVTXPeer $6.93▼-6.98% Cap $371.7MP/E -1.5x QuantScore38/100 | ACRSLeader $3.75▼-2.09% Cap $552.0MP/E -6.5x QuantScore47/100 | AGMBPeer $9.05▼-2.27% Cap $445.7MP/E -10.2x QuantScore43/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
55/100 |
48/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 50/100 | 67/100 |
Growth Revenue / earnings growth & margins | 20/100 | 40/100 | 0/100 |
Sentiment Analyst ratings, targets & revisions | 50/100 | 93/100 | 100/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -1.5x | -6.5x | -10.2x |
Forward P/E (next FY) | -2.4x | -5.8x | -5.2x |
EV / EBITDA (TTM) | -2.9x | -7.1x | -5.0x |
Price / Sales | 6299.3x | 67.2x | — |
Price / Free Cash Flow | -5.6x | -8.9x | -14.8x |
PEG ratio | 0.01 | -0.14 | -0.10 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 2 / 9 | — |
Altman Z-Score | 4.13 (Safe) | -2.73 (Distress) | — |
Total debt / equity | 0.00 | 0.00 | 0.00 |
Quick ratio | 19.3x | 3.5x | 12.9x |
Interest coverage | — | — | -257.1x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -86.6% | -58.2% | — |
Net income growth YoY | -122.8% | +50.8% | -35.2% |
Gross margin (TTM) | -16861.0% | 95.6% | 0.0% |
Operating margin (FY) | -123601.7% | -975.9% | — |
FCF margin (FY) | -87216.9% | -602.0% | — |
5. Trailing price performancePrice change over period |
1M return | -55.9% | -30.3% | -14.5% |
3M return | -62.4% | -28.3% | -27.7% |
6M return | -50.2% | -12.8% | -18.1% |
Year to date | -61.8% | +24.6% | -38.2% |
1Y return | -60.6% | +74.4% | -38.2% |
3Y return | -73.0% | -24.5% | -38.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.9859 -85.8% premium | $-0.8247 -122.0% premium | $1.90 -79.0% premium |
Wall Street consensus target | $37.86 +446.3% · range $10.00–$60.00 | $10.75 +186.7% · range $10.00–$12.00 | $35.00 +286.7% · range $35.00–$35.00 |
Consensus stance | 60% Buy30% Hold10% Sell | 81% Buy19% Hold0% Sell | — |